← All Sponsors
SPONSOR

Genmab

Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 3, Phase 1
Conditions studied: Non-Hodgkin LymphomaOvarian CancerPlatinum-sensitive Ovarian CancerPSOCAdvanced Malignant Solid TumorsMetastatic Malignant Solid Tumors
NCT05283720 Phase 2
Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma
United States, China, Czechia View Trial →
NCT07225270 Phase 3
Recruiting

Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

Ovarian Cancer
United States, Japan View Trial →
NCT06573294 Phase 1
Recruiting

Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors

Advanced Malignant Solid Tumors
United States, Japan, Spain View Trial →